Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease.
Kunkler
R B
RB
Leicester General Hospital, UK.
Osborn
D E
DE
Abbott
R J
RJ
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010479:Pergolide / Q000009:adverse effects*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced*
D000978:Antiparkinson Agents; D010479:Pergolide